Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...

Announcing a new article publication for BIO Integration journal. Neurologic disorders currently affect approximately 100 ...

Australia 2 Gene Therapy Research Unit, The Children’s Hospital, Westmead and Children’s Medical Research Institute, Sydney, NSW, Australia Correspondence to: Professor Trent Department of Molecular ...

Need for standardized measurement methods in gene therapy Date: January 13, 2025 Source: National Institute of Standards and Technology (NIST) Summary: Scientists looked at multiple techniques ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Global biopharmaceutical manufacturing firm Rentschler Biopharma will shutter its United Kingdom facility as the ...

Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used for some ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three-to-six times each week.

The gene therapy delandistrogene moxeparvovec-rokl showed clinically meaningful benefits and disease stabilization at 2 years ...